Results 181 to 190 of about 124,281 (312)

Biocontrol for Shrimp Disease: Comprehensive Review and a Bacterial Disease Biocontrol Practice

open access: yesReviews in Aquaculture, Volume 18, Issue 3, June 2026.
ABSTRACT Biocontrol is a key strategy for disease control, as it is environmentally friendly and widely applicable. This review elaborates on biocontrol in aquaculture, particularly in shrimp culture. Biocontrol in shrimp culture mainly relies on four strategies: (i) direct kill pathogen by Bdellovibrio or bacteriophages; (ii) suppression of intestinal
Xinyi He   +11 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, Volume 20, Issue 5, Page 1323-1346, May 2026.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Unraveling the miR-144-3p/PUMA pathway: a novel regulator of FDX1-mediated cuproptosis in colorectal cancer. [PDF]

open access: yesCell Oncol (Dordr)
Jia G   +11 more
europepmc   +1 more source

Does Your Classmatesʼ Early Childhood Education Experience Affect Your Non‐Cognitive/Socio‐Emotional Skills?

open access: yesAsia &the Pacific Policy Studies, Volume 13, Issue 2, May 2026.
ABSTRACT We investigate whether having more classmates with ECE experience affects junior high school studentsʼ non‐cognitive/socio‐emotional skills. We draw on panel data from the China Education Panel Survey (CEPS) and leverage the exogenous variation in classroom ECE experience composition brought by the random assignment of students when they ...
Yuhe Guo, Chengfang Liu, Yalin Tang
wiley   +1 more source

Allosteric regulation of BH3-in-groove interactions by tail anchors of BCL-xL complexes limits BH3 mimetic antagonism. [PDF]

open access: yesNat Commun
Maillet L   +8 more
europepmc   +1 more source

Fianlimab, a human lymphocyte activation gene‐3 monoclonal antibody, in combination with cemiplimab: Tumor‐specific expansion cohorts in advanced malignancies

open access: yesCancer, Volume 132, Issue 9, 1 May 2026.
Abstract Background The dose escalation phase of a first‐in‐human (FIH) study demonstrated acceptable safety and preliminary antitumor activity of fianlimab (anti‐lymphocyte activation gene‐3 [LAG‐3]) as monotherapy and in combination with cemiplimab (anti‐programmed cell death‐1 [PD‐1]). Here, the authors present safety and clinical activity data from
Tae Min Kim   +25 more
wiley   +1 more source

Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Osteosarcoma is the most common bone cancer in children and young adults. Its prognosis has not improved significantly since the introduction of the chemotherapy regimen established about 40 years ago, highlighting the need for new therapeutic strategies.
Natalie Aderhold   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy